[Federal Register Volume 71, Number 186 (Tuesday, September 26, 2006)]
[Notices]
[Pages 56159-56162]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E6-15729]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Notice of Listing of Grants for Research Projects

AGENCY: National Institutes of Health, Department of Health and Human 
Services.

ACTION: Notice.

-----------------------------------------------------------------------

[[Page 56160]]

SUMMARY: Section 52.1(b) of the regulations governing grants for 
research projects, codified at 42 CFR part 52, authorizes the Secretary 
of Health and Human Services to publish periodically a list of all of 
the research project grant programs to which the research project grant 
regulations apply. This Notice provides the most recent list of the 
programs covered by the regulations and supersedes the prior Notice 
published on November 25, 2003 (68 FR 66114-66117).

DATES: Effective Date: September 26, 2006.

FOR FURTHER INFORMATION CONTACT: Jerry Moore, NIH Regulations Officer, 
Office of Management Assessment, 6011 Executive Boulevard, Room 601, 
MSC 7669, Rockville, MD 20892, telephone 301-496-4607 (not a toll-free 
number), fax 301-402-0169, e-mail [email protected].

SUPPLEMENTARY INFORMATION: The National Institutes of Health (NIH) 
published a final rule in the Federal Register on October 24, 1996 (61 
FR 55102-55106), amending the regulations at 42 CFR part 52, Grants for 
Research Projects, which govern Public Health Service (PHS) research 
project grants. We amended the regulations to apply to all research 
project grant programs administered by PHS and its components, 
including the programs administered by NIH, except for grants for 
health services research, demonstrations, and evaluation projects 
administered by the Agency for Healthcare Research and Quality (AHRQ), 
to make it unnecessary to include a long list of programs in the 
regulations or to go through the lengthy process of amending the 
regulations each time a new program is established. At that time, we 
provided in the preamble a listing of the applicable programs and 
indicated that we would publish periodically a list of the research 
project grant programs to which the regulations apply, and that the 
applicability of the regulations to new programs would be announced as 
PHS components initiated new programs.
    Subsequently, we published the Notice entitled, ``Notice of Listing 
of Grants for Research Projects,'' in the Federal Register on November 
25, 2003. In the Notice we provided an updated list of programs to 
which the regulations at part 52 apply that reflected the addition of 
new authorities in sections 317J, 317K, 317L, 330E, 399M, 399N, 409E, 
434A, 445I, 447B, and 1261 of the Public Health Service Act (PHS Act), 
as amended.
    We are now publishing a further updated list that reflects the 
addition of the new authority in subsections (a) and (f) of section 
485D of the PHS Act, as amended, concerning research in complementary 
and alternative medicine. Specifically, the authority in subsection (a) 
concerns the conduct and support of basic and applied research 
(including both intramural and extramural research), research training, 
and dissemination of health information with respect to identifying, 
investigating, and validating complementary and alternative treatment, 
diagnostic and prevention modalities, and disciplines and systems of 
complementary and alternative medicine. Subsection (f) concerns the 
conduct and support of high quality, rigorous scientific reviewing of 
complementary and alternative medicine modalities, including outcomes 
research and investigations, epidemiological studies, health services 
research, basic sciences research, clinical trials, and other 
appropriate research and investigational activities.
    The regulations codified at 42 CFR part 52 apply to all PHS 
research project grant programs except for grants for health services 
research, demonstrations, and evaluation projects administered by the 
AHRQ. Specifically, the research project grant authorities to which the 
Grants for Research Projects regulations apply include:
    (1) Research into the cause, diagnosis, treatment, control, or 
prevention of the physical or mental diseases, injuries, or impairments 
to human life, as authorized by sections 301, 302, and related 
provisions of the PHS Act (42 U.S.C. 241, 242);
    (2) Research into the prevention and control of childhood lead 
poisoning, as authorized under section 301 of the PHS Act (42 U.S.C. 
241);
    (3) Epidemiologic studies and State-based research capacity 
building projects for the prevention of primary and secondary 
disabilities, as authorized under section 301 of the PHS Act (42 U.S.C. 
241);
    (4) Ecological and epidemiologic research studies in Lyme disease, 
including disease surveillance, development and evaluation of 
prevention and control studies, and development of improved diagnostic 
tests, as authorized under section 301 of the PHS Act (42 U.S.C. 241);
    (5) Research for the development of knowledge and approaches to the 
epidemiology, eitology, diagnosis, treatment, control, and prevention 
of narcotic addiction and intravenous (IV)-related AIDS and drug abuse, 
as authorized under sections 301 and 302 of the PHS Act (42 U.S.C. 241, 
242);
    (6) Investigations to identify strategies for prevention of 
childhood deaths from diarrhea, as authorized under sections 301 and 
317(k) of the PHS Act (42 U.S.C. 241, 247b(k));
    (7) HIV/AIDS surveillance, HIV serosurveillance surveys and 
studies, and epidemiologic research studies of AIDS and HIV infection, 
as authorized under sections 301 and 317(k) of the PHS Act (42 U.S.C. 
241, 247b(k));
    (8) Surveillance and epidemiologic studies for the prevention of 
infectious diseases and injuries in children in child day care 
settings, as authorized under sections 301, 317(k), and 391 of the PHS 
Act (42 U.S.C. 241, 247b(k)(3), 280(b));
    (9) Research into prevention and control of tuberculosis, 
especially research concerning strains of tuberculosis resistant to 
drugs and research concerning cases of tuberculosis that affect certain 
populations, as authorized by section 317E of the PHS Act (42 U.S.C. 
247b-6);
    (10) Research with respect to education and training for health 
professionals and the general public relating to the effects of folic 
acid in preventing birth defects, as authorized by section 317J of the 
PHS Act (42 U.S.C. 247b-11);
    (11) Research relating to risk factors, prevention strategies, and 
the roles of the family, health care providers, and the community in 
safe motherhood, as authorized by section 317K of the PHS Act, as 
amended by section 901 of Public Law 106-310 (42 U.S.C. 424b-12);
    (12) Epidemiological research on the prevention of prenatal and 
postnatal smoking, alcohol, and illegal drug use, as authorized by 
section 317L of the PHS Act, as amended by section 911 of Public Law 
106-310 (42 U.S.C. 247b-13);
    (13) Research relating to intervention strategies to improve the 
lives of persons with epilepsy, particularly children, as authorized by 
section 330E of the PHS Act, as amended by section 801 of Public Law 
106-310 (42 U.S.C. 254c-5);
    (14) Injury prevention and control research, as authorized by 
section 391 of the PHS Act (42 U.S.C. 280b);
    (15) Research relating to the efficacy of new screening techniques 
and technology, including clinical studies of screening methods and 
studies on the efficacy of new interventions regarding hearing loss in 
infants, as authorized by section 399M of the PHS Act, as

[[Page 56161]]

amended by section 702 of Public Law 106-310 (42 U.S.C. 280g-1);
    (16) Research relating to improving the outcomes among children 
with childhood cancers and resultant secondary conditions, as 
authorized by section 399N of the PHS Act, as amended by section 1101 
of Public Law 106-310 (42 U.S.C. 280g-2);
    (17) Research on osteoporosis, Paget's disease, and related bone 
disorders, as authorized by section 409A of the PHS Act (42 U.S.C. 
284e);
    (18) Research relating to autoimmune diseases, as authorized by 
section 409E of the PHS Act, as amended by section 1901 of Public Law 
106-310 (42 U.S.C. 284i);
    (19) Long-term epidemiology studies relating to type 1 or juvenile 
diabetes, as authorized by section 434A of the PHS Act, as amended by 
section 402 of Public Law 106-310 (42 U.S.C. 285c-9);
    (20) Biomedical research in areas relating to Alzheimer's disease 
and related dementias, as authorized by section 445B of the PHS Act (42 
U.S.C. 285e-4);
    (21) Clinical research and training to enhance and promote the 
translation of new scientific knowledge into clinical practice related 
to the diagnosis, care, and treatment of individuals with Alzheimer's 
disease, as authorized by section 445I of the PHS Act (42 U.S.C. 285e-
10a);
    (22) Clinical research and training to enhance and promote the 
translation of new scientific knowledge into clinical practice related 
to the diagnosis, care, and treatment of individuals with sexually 
transmitted diseases, as authorized by section 447B of the PHS Act, as 
amended by section 901 of Public Law 106-505 (42 U.S.C. 285f-3);
    (23) Research relating to medical rehabilitation, as authorized by 
section 452 of the PHS Act (42 U.S.C. 285g-4);
    (24) Research on clinical and health services on eye care and 
diabetes, as authorized by section 456 of the PHS Act (42 U.S.C. 285i-
1);
    (25) Research on multiple sclerosis, especially research on the 
effects of genetics and hormonal changes on the progress of the 
disease, as authorized by section 460 of the PHS Act (42 U.S.C. 285j-
3);
    (26) Research on the social, behavioral, and biomedical etiology, 
the mental and physical health consequences, and the social and 
economic consequences of alcohol abuse and alcoholism, as authorized by 
464H of the PHS Act (42 U.S.C. 285n);
    (27) Health services research activities with respect to the 
prevention of alcohol abuse and treatment of alcoholism, as authorized 
by section 464H of the PHS Act (42 U.S.C. 285n) and as defined in 
section 409 of the PHS Act (42 U.S.C. 284d);
    (28) Research under the Medication Development Program to encourage 
and promote the development and use of medications to treat drug 
addiction; and to collect, analyze, and disseminate data, as authorized 
by section 464P of the PHS Act (42 U.S.C. 285o-4);
    (29) Research on health-related educational technologies, on 
medical library science and related activities, and for the development 
or dissemination of new knowledge, techniques, systems, and equipment 
for processing, storing, retrieving, and distributing information 
pertaining to health sciences, as authorized by section 473 of the PHS 
Act (42 U.S.C. 286b-4);
    (30) Research with respect to identifying, investigating, and 
validating complementary and alternative treatment, diagnostic and 
prevention modalities, disciplines and systems of complementary and 
alternative medicine, as authorized by section 485D (a) and (f) of the 
PHS Act, as amended (42 U.S.C. 287c-21(a), (f));
    (31) Research in the biomedical, contraceptive, development, 
behavioral and program implementation fields related to family planning 
and population, as authorized by section 1004 of the PHS Act (42 U.S.C. 
300a-2);
    (32) Basic and applied research regarding traumatic brain injury, 
including the development, modification, and evaluation of therapies 
and programs of rehabilitation toward reaching or restoring normal 
capabilities, as authorized by section 1261 of the PHS Act, as amended 
by section 1301 of Public Law 106-310 (42 U.S.C. 300d-61);
    (33) Research on the causes, consequences, and approaches of coping 
with adolescent sexual relations, contraceptive use, pregnancy, and 
parenthood, as authorized by section 2008 of the PHS Act (42 U.S.C. 
300z-7);
    (34) Research relating to the evaluation of drug treatments for 
AIDS not approved by the Commissioner of Food and Drugs, as authorized 
by section 2314 of the PHS Act (42 U.S.C. 300cc-14);
    (35) International research relating to the development and 
evaluation of vaccines and treatments for AIDS, as authorized by 
section 2315 of the PHS Act (42 U.S.C. 300cc-15);
    (36) Long-term research into treatments for AIDS, as authorized by 
section 2320 of the PHS Act (42 U.S.C. 300cc-20);
    (37) Research relating to AIDS conducted outside the United States 
by qualified foreign professionals and collaborative research involving 
American and foreign participants, as authorized by section 2354 of the 
PHS Act (42 U.S.C. 300cc-41);
    (38) Basic research to identify, characterize, and quantify risks 
to human health from air pollutants, as authorized by section 103 of 
the Clean Air Act, as amended (42 U.S.C. 7403);
    (39) Electronic product radiation control research programs 
designed to protect the public health and safety from electronic 
product radiation, as authorized by section 532 of the Federal Food, 
Drug, and Cosmetic Act, as amended (21 U.S.C. 360ii);
    (40) Research into areas where a microgravity environment may 
contribute to significant progress in the understanding and treatment 
of diseases and other medical conditions, as authorized by section 603 
of the National Aeronautics and Space Administration Authorization Act, 
Fiscal Year 1993 (42 U.S.C. 2487b);
    (41) Support for radiation studies and research, as authorized 
under section 301 of the PHS Act (42 U.S.C. 241) and by section 20(a) 
of the Occupational Safety and Health Act of 1970 (29 U.S.C. 669(a));
    (42) Research on occupational safety and health problems in 
industry, as authorized by section 20(a) of the Occupational Safety and 
Health Act of 1970 (29 U.S.C. 669(a)) and section 501 of the Federal 
Coal Mine Health and Safety Act of 1969 (30 U.S.C. 951); and
    (43) Research to stimulate health-related technological innovation 
especially through the use of small business, minority, and 
disadvantaged firms and increased private sector commercialization of 
innovations derived from Federal research and development, as 
authorized under section 301 of the PHS Act (42 U.S.C. 241), in 
accordance with the procedures prescribed pursuant to section 2[9] of 
the Small Business Innovation Development Act of 1982, as amended (15 
U.S.C. 638).

    The Catalog of Federal Domestic Assistance (CFDA) numbered 
programs affected by title 42 of the Code of Federal regulations, 
part 52, are:

93.113--Biological Response to Environmental Health Hazards
93.114--Applied Toxicological Research and Testing
93.115--Biometry and Risk Estimation--Health Risks from 
Environmental Exposures
93.118--Acquired Immunodeficiency Syndrome (AIDS) Activity
93.121--Oral Diseases and Disorders Research

[[Page 56162]]

93.135--Centers for Research and Demonstration for Health Promotion 
and Disease Prevention
93.136--Injury Prevention and Control Research and State and 
Community Based Programs
93.172--Human Genome Research
93.173--Research Related to Deafness and Communication Disorders
93.184--Disabilities Prevention
93.213--Research and Training in Complementary and Alternative 
Medicine
93.242--Mental Health Research Grants
93.262--Occupational Safety and Health Program
93.271--Alcohol Research Career Development Awards for Scientists 
and Clinicians
93.273--Alcohol Research Programs
93.279--Drug Abuse and Addiction Research Programs
93.281--Mental Health Research Career/Scientist Development Awards
93.283--Centers for Disease Control and Prevention--Investigations 
and Technical Assistance
93.361--Nursing Research
93.389--National Center for Research Resources
93.390--Academic Research Enhancement Award
93.393--Cancer Cause and Prevention Research
93.394--Cancer Detection and Diagnosis Research
93.395--Cancer Treatment Research
93.396--Cancer Biology Research
93.821--Biophysics and Physiological Sciences Research
93.837--Heart and Vascular Diseases Research
93.838--Lung Diseases Research
93.839--Blood Diseases and Resources Research
93.846--Arthritis, Musculoskeletal and Skin Diseases Research
93.847--Diabetes, Endocrinology and Metabolic Research
93.848--Digestive Diseases and Nutrition Research
93.849--Kidney Diseases, Urology and Hematology Research
93.853--Clinical Research Related to Neurological Disorders
93.855--Allergy, Immunology, and Transplantation Research
93.856--Microbiology and Infectious Diseases Research
93.859--Biomedical Research and Research Training
93.865--Child Health and Human Development Extramural Research
93.866--Aging Research
93.867--Vision Research
93.879--Medical Library Assistance
93.941--HIV Demonstration, Research, Public and Professional 
Education Projects
93.942--Research, Treatment and Education Programs on Lyme Disease 
in the United States
93.943--Epidemiologic Research Studies of Acquired Immunodeficiency 
Syndrome (AIDS) and Human Immunodeficiency Virus (HIV) Infection in 
Selected Population Groups
93.947--Tuberculosis Demonstration, Research, Public and 
Professional Education

    Dated: September 19, 2006.
Elias A. Zerhouni,
Director, National Institutes of Health.
    Approved: September 19, 2006.
Michael O. Leavitt,
Secretary.
[FR Doc. E6-15729 Filed 9-25-06; 8:45 am]
BILLING CODE 4140-01-P